Class information for:
Level 1: FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3837 1824 50.2 93%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 FOXP3 Author keyword 17 11% 8% 155
2 TUMOR INFILTRATING LYMPHOCYTES Author keyword 13 15% 4% 79
3 INTEGRAT CANC IMMUNOL Address 12 56% 1% 15
4 U1015 Address 11 29% 2% 33
5 TUMOUR INFILTRATING LYMPHOCYTES Author keyword 9 31% 1% 25
6 EQUIPE ELLISEE LIGUE CANC 11 Address 7 31% 1% 18
7 INTEGRAT CANC IMMUNOL TEAM Address 6 71% 0% 5
8 CELL DEATH THER Y CDRT UNIT Address 6 100% 0% 4
9 U848 Address 5 12% 2% 37
10 ANTI CD25 ANTIBODY Author keyword 4 67% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 FOXP3 17 11% 8% 155 Search FOXP3 Search FOXP3
2 TUMOR INFILTRATING LYMPHOCYTES 13 15% 4% 79 Search TUMOR+INFILTRATING+LYMPHOCYTES Search TUMOR+INFILTRATING+LYMPHOCYTES
3 TUMOUR INFILTRATING LYMPHOCYTES 9 31% 1% 25 Search TUMOUR+INFILTRATING+LYMPHOCYTES Search TUMOUR+INFILTRATING+LYMPHOCYTES
4 ANTI CD25 ANTIBODY 4 67% 0% 4 Search ANTI+CD25+ANTIBODY Search ANTI+CD25+ANTIBODY
5 FOXP3 PROTEIN HUMAN 4 75% 0% 3 Search FOXP3+PROTEIN++HUMAN Search FOXP3+PROTEIN++HUMAN
6 TREG DEPLETION 4 75% 0% 3 Search TREG+DEPLETION Search TREG+DEPLETION
7 IMMUNOGENIC CELL DEATH 4 19% 1% 18 Search IMMUNOGENIC+CELL+DEATH Search IMMUNOGENIC+CELL+DEATH
8 TILS 3 27% 1% 10 Search TILS Search TILS
9 CD4CD25FOXP3REGULATORY T CELLS 3 50% 0% 4 Search CD4CD25FOXP3REGULATORY+T+CELLS Search CD4CD25FOXP3REGULATORY+T+CELLS
10 FORKHEAD BOX P3 2 19% 1% 11 Search FORKHEAD+BOX+P3 Search FORKHEAD+BOX+P3

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INCREASED POPULATIONS 90 77% 3% 61
2 TUMOR IMMUNITY 21 15% 7% 126
3 CALRETICULIN EXPOSURE 15 30% 2% 41
4 ESOPHAGEAL CANCERS 11 42% 1% 21
5 IMMUNOSCORE 8 75% 0% 6
6 MULTIDRUG REGIMEN 8 100% 0% 5
7 LOW DOSE CYCLOPHOSPHAMIDE 8 16% 2% 43
8 NODE LIKE STRUCTURES 8 62% 0% 8
9 ANTICANCER CHEMOTHERAPY 7 25% 1% 26
10 FOSTERS IMMUNE PRIVILEGE 7 32% 1% 18

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 2015 14 42 62%
The immune contexture in human tumours: impact on clinical outcome 2012 318 165 50%
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours 2014 56 62 52%
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion 2011 762 61 30%
Immunogenic Cell Death in Cancer Therapy 2013 176 102 26%
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature 2012 71 75 89%
Regulatory T cells in cancer immunotherapy 2014 43 63 37%
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? 2014 39 43 40%
Immune infiltration in human tumors: a prognostic factor that should not be ignored 2010 191 93 45%
Cancer classification using the Immunoscore: a worldwide task force 2012 77 33 58%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTEGRAT CANC IMMUNOL 12 56% 0.8% 15
2 U1015 11 29% 1.8% 33
3 EQUIPE ELLISEE LIGUE CANC 11 7 31% 1.0% 18
4 INTEGRAT CANC IMMUNOL TEAM 6 71% 0.3% 5
5 CELL DEATH THER Y CDRT UNIT 6 100% 0.2% 4
6 U848 5 12% 2.0% 37
7 U805 4 24% 0.8% 14
8 POLE BIOL 3 15% 1.2% 21
9 ERM 0208 3 100% 0.2% 3
10 MED ONCOL PHARMACOL SECT 3 100% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000209585 RECOMBINANT VACCINE GRP//ABSCOPAL EFFECT//IMMUNOGENIC TUMOR CELL DEATH
2 0.0000166106 UNITA OPERAT ASSISTENZIALE GINECOL ONCOL//CD1A//CDLA
3 0.0000164168 CCDC134//TUMOR IMMUN TOLERANCE SECT//ANTIGEN SPECIFIC CTL FUNCTION
4 0.0000147366 MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELL
5 0.0000143017 FOXP3//REGULATORY T CELLS//REGULATORY T CELL
6 0.0000124043 CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN
7 0.0000117716 BELAGENPUMATUCEL L//SRL172//PA MSHA
8 0.0000102338 CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS
9 0.0000097397 B7 H4//PD 1//PD L1
10 0.0000094654 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN